SignalTech/AI
INmune Bio, Quantum Computing to collaborate on XPro Alzheimer's treatment
INmune Bio and Quantum Computing collaboration targets XPro Alzheimer's treatment.
Context
What happened: INmune Bio (INMB) and Quantum Computing (QUBT) agreed to collaborate on advancing INmune's Alzheimer's disease candidate XPro1595 (XPro) and on finding potential new indications for the asset.
Why it matters: The collaboration will focus on using quantum computing, AI, and data analytics, per the companies.
Total: 322 characters.
What changed
INmune Bio (INMB) and Quantum Computing (QUBT) agreed to collaborate on advancing INmune's Alzheimer's disease candidate XPro1595 (XPro) and on finding potential new indications for the asset.
Why it matters
The collaboration will focus on using quantum computing, AI, and data analytics, per the companies.
Total: 322 characters.
← Dashboard
Oct 14, 2026 03:04 PM ET